applepharmaceutical@gmail.com
Nelvir

PRODUCT DETAILS

Trade name : Nelvir
Active ingredient : Nelfinavir
Strength availability : 250mg
Manufactured by : Cipla
Package : 100 tablets in a container
Classified as : Anti-retroviral drug.

for MORE INFORMATION !!!

Nelvir is type of HIV-1 protease inhibitor and includes in group of anti-retroviral drugs. Nelvir needed for inhibition of HIV from reproducing in your body. The drug also required to treat a virus which cause acquired immunodeficiency syndrome. Nelvir is not cure for HIV or AIDS. Nelvir is prescription drug which is used under supervision of medical practioners.

DOSAGE

For adult the usual dose for HIV infections in patients administered as 1250 mg given orally twice a day or 750mg given orally 3 times a day The drug administer in combination with other antiretroviral agents for treatment of HIV-1 Infection. For Non occupational Exposure the dose US CDC prescribed as 1250mg two times a day orally or 750mg three times a day orally given for 28 days. For pediatric dose age 2 to less than 13 years prescribed dose is 45 to 55 mg/kg given orally twice a day Or 25 to 35 mg/kg given orally three times a day. Maximum dose is 2500mg/day. Age 13 years or older = 1250mg given orally twice times a day or 750mg taken orally three times a day. The children weighing 16 kg or more administer 250mg for twice-daily

PHARMACOLOGY

Nelfinavir which will join to the site of HIV-1 protease activity and inhibits cleavage of viral Gag-Pol polyprotein precursors into divide the functional proteins necessary for infectious HIV. This will causes to immature formation, noninfectious viral particles.

ADME

Absorption: AUC is highly variable in pediatric patients because increased clearance, problems with compliance and inconsistent food intake with dosing. The time to high plasma concentration is 2 to 4 hours.
Distribution: Volume of distribution is 2 to 7 L/kg
Metabolism :
Mainly metabolized through Hepatic via CYP2C19 and 3A4
Excretion :
The elimination of drug through feces 98% to 99% and as metabolite 78% and unchanged drug as 22% and through urine 1% to 2%.

PRECAUTION

If patients have Diabetes mellitus/hyperglycemia. Inform the doctor before taking treatment with Nelvir Hemophilia: increased bleeding level with nelfinavir treatment Fat distribution Risk of serious adverse reaction due to drug interaction Hepatic impairment: the drug should not be used Phenylketourics ; nelfinavir contains phenylalanine which is harmful to patients with phenylketouria. Immune Reconstitution Syndrome

DRUG INTERACTION

Concomitant use with antacids, Phenobarbital, carbamazepine, aminoglutethimide, phenytoin, rifampicin, nafcillin, nevirapine, omeprazole will reduce the levels of nevimune Interaction of Nelvir with antifungal agents, cimetidine, Efavirenz wills increases serum levels. Reduced plasma effects while concomitant use with hormonal contraceptives, methadone, theophylline derivatives

CONTRAINDICATION

Nelfinavir combination with CYP3A for clearance is contraindicated

OVERDOSAGE

The highest dose of Zepdon is 1600mg as a single dose The highest dose of Zepdon is 800mg as two times a day. Even if over dosage of Zepdon occur patient must be; Start with supportive measures and excrete the unabsorbed dose from GI tract. Monitor the manifestation occurs due to over dosage

MISSED DOSE

If you missed dose, have it soon If next dose time reached then avoid missed dose. And follow regular timings Please consult with doctor.

SIDE EFFECTS

Side effects by Clinical trials experience- adult and adolescents (13 yrs and older) Hemic/lymphatic system: anemia, leucopenia and thrombocytopenia Metabolic/nutritional: liver function test abnormalities amylase, SGOT, SGPT, hypoglycemia, dehydration Digestive system: diarrhea, nausea, flatulence, epigastric pain Skin /appendages: rash Musculoskeletal system: arthralgia, arthritis, cramps,myalgia Respiratory: dyspnae, pharyngitis, rhinitis, and sinusitis. Special sense: acute iritis and eye disorder.
Postmarketing Expeience :
Qtc prolongation Jaundice Hypersensitivity reaction Bilirubinemia, metabolic acidosis.

We'd Like to Hear From You!

PRESCRIPTION POLICY

1. myapplepharma.com, a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
2. myapplepharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.
3. If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.
4. The drug information provided in the myapplepharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.
5. myapplepharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from myapplepharma.com.
6. At myapplepharma.com, a Caregiver can order prescription medicines on your behalf.


This information should not be used to decide whether to accept this product or any other medicine. Only a health care provider is knowledge and training to decide that a medicine suitable for a specific patient. This information does not support any drug as safe, are effective or approved for the treatment of any patient or health condition. It's simple a brief overview of general information about this product. It does not include all information on possible applications, indications, warnings, precautions, interactions, adverse effects or risks that may be relevant to this product. This information is not specific medical advice and does not replace information obtained from your health care provider. You should check with your health care provider for complete information about the risks and benefits of using this product.